|
1
|
Gerweck LE and Seetharaman K: Cellular pH
gradient in tumor versus normal tissue: Potential exploitation for
the treatment of cancer. Cancer Res. 56:1194–1198. 1996.PubMed/NCBI
|
|
2
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Webb BA, Chimenti M, Jacobson MP and
Barber DL: Dysregulated pH: A perfect storm for cancer progression.
Nat Rev Cancer. 11:671–677. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hashim AI, Zhang X, Wojtkowiak JW,
Martinez GV and Gillies RJ: Imaging pH and metastasis. NMR Biomed.
24:582–591. 2011.PubMed/NCBI
|
|
5
|
Michelakis ED, Webster L and Mackey JR:
Dichloroacetate (DCA) as a potential metabolic-targeting therapy
for cancer. Br J Cancer. 99:989–994. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McFate T, Mohyeldin A, Lu H, Thakar J,
Henriques J, Halim ND, Wu H, Schell MJ, Tsang TM, Teahan O, et al:
Pyruvate dehydrogenase complex activity controls metabolic and
malignant phenotype in cancer cells. J Biol Chem. 283:22700–22708.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonnet S, Archer SL, Allalunis-Turner J,
Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta
L, Bonnet S, et al: A mitochondria-K+ channel axis is
suppressed in cancer and its normalization promotes apoptosis and
inhibits cancer growth. Cancer Cell. 11:37–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Preter G, Neveu MA, Danhier P, Brisson
L, Payen VL, Porporato PE, Jordan BF, Sonveaux P and Gallez B:
Inhibition of the pentose phosphate pathway by dichloroacetate
unravels a missing link between aerobic glycolysis and cancer cell
proliferation. Oncotarget. 7:2910–2920. 2016.
|
|
9
|
Dunbar EM, Coats BS, Shroads AL, Langaee
T, Lew A, Forder JR, Shuster JJ, Wagner DA and Stacpoole PW: Phase
1 trial of dichloroacetate (DCA) in adults with recurrent malignant
brain tumors. Invest New Drugs. 32:452–464. 2014. View Article : Google Scholar
|
|
10
|
Zhang X, Lin Y and Gillies RJ: Tumor pH
and its measurement. J Nucl Med. 51:1167–1170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gillies RJ, Liu Z and Bhujwalla Z:
31P-MRS measurements of extracellular pH of tumors using
3-aminopropylphosphonate. Am J Physiol. 267:C195–C203.
1994.PubMed/NCBI
|
|
12
|
Garcia-Martin ML, Martinez GV, Raghunand
N, Sherry AD, Zhang S and Gillies RJ: High resolution pH(e) imaging
of rat glioma using pH-dependent relaxivity. Magn Reson Med.
55:309–315. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gallagher FA, Kettunen MI, Day SE, Hu DE,
Ardenkjaer- Larsen JH, Zandt R, Jensen PR, Karlsson M, Golman K,
Lerche MH, et al: Magnetic resonance imaging of pH in vivo using
hyperpolarized 13C-labelled bicarbonate. Nature.
453:940–943. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Serrao EM and Brindle KM: Potential
clinical roles for metabolic imaging with hyperpolarized
[1-13C]pyruvate. Front Oncol. 6:592016. View Article : Google Scholar
|
|
15
|
Reineri F, Daniele V, Cavallari E and Aime
S: Assessing the transport rate of hyperpolarized pyruvate and
lactate from the intra- to the extracellular space. NMR Biomed.
29:1022–1027. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reineri F, Boi T and Aime S: Parahydrogen
induced polarization of 13C carboxylate resonance in
acetate and pyruvate. Nat Commun. 6:58582015. View Article : Google Scholar
|
|
17
|
Viale A, Reineri F, Dastrù W and Aime S:
Hyperpolarized (13) C-pyruvate magnetic resonance imaging in cancer
diagnostics. Expert Opin Med Diagn. 6:335–345. 2012. View Article : Google Scholar
|
|
18
|
Menzel MI, Farrell EV, Janich MA, Khegai
O, Wiesinger F, Nekolla S, Otto AM, Haase A, Schulte RF and
Schwaiger M: Multimodal assessment of in vivo metabolism with
hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET
imaging in hepatocellular carcinoma tumor-bearing rats. J Nucl Med.
54:1113–1119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rivlin M and Navon G: Glucosamine and
N-acetyl glucosamine as new CEST MRI agents for molecular imaging
of tumors. Sci Rep. 6:326482016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu X, Chan KW, Knutsson L, Artemov D, Xu
J, Liu G, Kato Y, Lal B, Laterra J, McMahon MT, et al: Dynamic
glucose enhanced (DGE) MRI for combined imaging of blood-brain
barrier break down and increased blood volume in brain cancer. Magn
Reson Med. 74:1556–1563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rivlin M, Tsarfaty I and Navon G:
Functional molecular imaging of tumors by chemical exchange
saturation transfer MRI of 3-O-Methyl-D-glucose. Magn Reson Med.
72:1375–1380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Walker-Samuel S, Ramasawmy R, Torrealdea
F, Rega M, Rajkumar V, Johnson SP, Richardson S, Gonçalves M,
Parkes HG, Arstad E, et al: In vivo imaging of glucose uptake and
metabolism in tumors. Nat Med. 19:1067–1072. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hingorani DV, Bernstein AS and Pagel MD: A
review of responsive MRI contrast agents: 2005–2014. Contrast Media
Mol Imaging. 10:245–265. 2015. View Article : Google Scholar
|
|
24
|
Longo DL, Dastrù W, Digilio G, Keupp J,
Langereis S, Lanzardo S, Prestigio S, Steinbach O, Terreno E,
Uggeri F, et al: Iopamidol as a responsive MRI-chemical exchange
saturation transfer contrast agent for pH mapping of kidneys. In
vivo studies in mice at 7. T Magn Reson Med. 65:202–211. 2011.
View Article : Google Scholar
|
|
25
|
Longo DL, Busato A, Lanzardo S, Antico F
and Aime S: Imaging the pH evolution of an acute kidney injury
model by means of iopamidol, a MRI-CEST pH-responsive contrast
agent. Magn Reson Med. 70:859–864. 2013. View Article : Google Scholar
|
|
26
|
Chen LQ, Howison CM, Jeffery JJ, Robey IF,
Kuo PH and Pagel MD: Evaluations of extracellular pH within in vivo
tumors using acidoCEST MRI. Magn Reson Med. 72:1408–1417. 2014.
View Article : Google Scholar :
|
|
27
|
Moon BF, Jones KM, Chen LQ, Liu P, Randtke
EA, Howison CM and Pagel MD: A comparison of iopromide and
iopamidol, two acidoCEST MRI contrast media that measure tumor
extracellular pH. Contrast Media Mol Imaging. 10:446–455. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang X, Song X, Ray Banerjee S, Li Y, Byun
Y, Liu G, Bhujwalla ZM, Pomper MG and McMahon MT: Developing
imidazoles as CEST MRI pH sensors. Contrast Media Mol Imaging.
11:304–312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Longo DL, Bartoli A, Consolino L, Bardini
P, Arena F, Schwaiger M and Aime S: In vivo imaging of tumor
metabolism and acidosis by combining PET and MRI-CEST pH imaging.
Cancer Res. 76:6463–6470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nanni P, de Giovanni C, Lollini PL,
Nicoletti G and Prodi G: TS/A: A new metastasizing cell line from a
BALB/c spontaneous mammary adenocarcinoma. Clin Exp Metastasis.
1:373–380. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lanzardo S, Conti L, Rooke R, Ruiu R,
Accart N, Bolli E, Arigoni M, Macagno M, Barrera G, Pizzimenti S,
et al: Immunotargeting of antigen xCT attenuates stem-like cell
behavior and metastatic progression in breast cancer. Cancer Res.
76:62–72. 2016. View Article : Google Scholar
|
|
32
|
Sun RC, Fadia M, Dahlstrom JE, Parish CR,
Board PG and Blackburn AC: Reversal of the glycolytic phenotype by
dichloroacetate inhibits metastatic breast cancer cell growth in
vitro and in vivo. Breast Cancer Res Treat. 120:253–260. 2010.
View Article : Google Scholar
|
|
33
|
Duan Y, Zhao X, Ren W, Wang X, Yu KF, Li
D, Zhang X and Zhang Q: In vitro and in vivo evaluation. Onco
Targets Ther. 6:189–198. 2013.
|
|
34
|
Takahashi M, Watari E and Takahashi H:
Dichloroacetate induces cell cycle arrest in human glioblastoma
cells persistently infected with measles virus: A way for
controlling viral persistent infection. Antiviral Res. 113:107–110.
2015. View Article : Google Scholar
|
|
35
|
Allen KT, Chin-Sinex H, DeLuca T,
Pomerening JR, Sherer J, Watkins JB III, Foley J, Jesseph JM and
Mendonca MS: Dichloroacetate alters Warburg metabolism, inhibits
cell growth, and increases the X-ray sensitivity of human A549 and
H1299 NSC lung cancer cells. Free Radic Biol Med. 89:263–273. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Madhok BM, Yeluri S, Perry SL, Hughes TA
and Jayne DG: Dichloroacetate induces apoptosis and cell-cycle
arrest in colorectal cancer cells. Br J Cancer. 102:1746–1752.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bowker-Kinley MM, Davis WI, Wu P, Harris
RA and Popov KM: Evidence for existence of tissue-specific
regulation of the mammalian pyruvate dehydrogenase complex. Biochem
J. 329:191–196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Babu E, Ramachandran S, CoothanKandaswamy
V, Elangovan S, Prasad PD, Ganapathy V and Thangaraju M: Role of
SLC5A8, a plasma membrane transporter and a tumor suppressor, in
the antitumor activity of dichloroacetate. Oncogene. 30:4026–4037.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Haugrud AB, Zhuang Y, Coppock JD and
Miskimins WK: Dichloroacetate enhances apoptotic cell death via
oxidative damage and attenuates lactate production in
metformin-treated breast cancer cells. Breast Cancer Res Treat.
147:539–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kumar A, Kant S and Singh SM: Novel
molecular mechanisms of antitumor action of dichloroacetate against
T cell lymphoma: Implication of altered glucose metabolism, pH
homeostasis and cell survival regulation. Chem Biol Interact.
199:29–37. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Robey IF and Martin NK: Bicarbonate and
dichloroacetate: Evaluating pH altering therapies in a mouse model
for metastatic breast cancer. BMC Cancer. 11:2352011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xintaropoulou C, Ward C, Wise A, Marston
H, Turnbull A and Langdon SP: A comparative analysis of inhibitors
of the glycolysis pathway in breast and ovarian cancer cell line
models. Oncotarget. 6:25677–25695. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kailavasan M, Rehman I, Reynolds S, Bucur
A, Tozer G and Paley M: NMR-based evaluation of the metabolic
profile and response to dichloroacetate of human prostate cancer
cells. NMR Biomed. 27:610–616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kinnaird A, Dromparis P, Saleme B, Gurtu
V, Watson K, Paulin R, Zervopoulos S, Stenson T, Sutendra G, Pink
DB, et al: Metabolic modulation of clear-cell renal cell carcinoma
with dichloroacetate, an inhibitor of pyruvate dehydrogenase
kinase. Eur Urol. 69:734–744. 2016. View Article : Google Scholar
|
|
45
|
Sanchez WY, McGee SL, Connor T, Mottram B,
Wilkinson A, Whitehead JP, Vuckovic S and Catley L: Dichloroacetate
inhibits aerobic glycolysis in multiple myeloma cells and increases
sensitivity to bortezomib. Br J Cancer. 108:1624–1633. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xie J, Wang BS, Yu DH, Lu Q, Ma J, Qi H,
Fang C and Chen HZ: Dichloroacetate shifts the metabolism from
glycolysis to glucose oxidation and exhibits synergistic growth
inhibition with cisplatin in HeLa cells. Int J Oncol. 38:409–417.
2011.
|
|
47
|
Longo DL, Sun PZ, Consolino L, Michelotti
FC, Uggeri F and Aime S: A general MRI-CEST ratiometric approach
for pH imaging: Demonstration of in vivo pH mapping with
iobitridol. J Am Chem Soc. 136:14333–14336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Longo DL, Michelotti F, Consolino L,
Bardini P, Digilio G, Xiao G, Sun PZ and Aime S: In vitro and in
vivo assessment of nonionic iodinated radiographic molecules as
chemical exchange saturation transfer magnetic resonance imaging
tumor perfusion agents. Invest Radiol. 51:155–162. 2016. View Article : Google Scholar
|
|
49
|
Anemone A, Consolino L and Longo DL:
MRI-CEST assessment of tumour perfusion using X-ray iodinated
agents: Comparison with a conventional Gd-based agent. Eur Radiol.
27:2170–2179. 2017. View Article : Google Scholar
|
|
50
|
Kato Y, Ozawa S, Miyamoto C, Maehata Y,
Suzuki A, Maeda T and Baba Y: Acidic extracellular microenvironment
and cancer. Cancer Cell Int. 13:892013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chen LQ, Howison CM, Spier C, Stopeck AT,
Malm SW, Pagel MD and Baker AF: Assessment of carbonic anhydrase IX
expression and extracellular pH in B-cell lymphoma cell line
models. Leuk Lymphoma. 56:1432–1439. 2015. View Article : Google Scholar
|
|
52
|
Mcvicar N, Li AX, Meakin SO and Bartha R:
Imaging chemical exchange saturation transfer (CEST) effects
following tumor-selective acidification using lonidamine. NMR
Biomed. 28:566–575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Marathe K, Mcvicar N, Li A, Bellyou M,
Meakin S and Bartha R: Topiramate induces acute intracellular
acidification in glioblastoma. J Neurooncol. 130:465–472. 2016.
View Article : Google Scholar : PubMed/NCBI
|
